 |
市场调查报告书
商品编码
1321789
数字 PCR (dPCR) 和实时 PCR (qPCR) 的全球市场 - 市场规模、份额、增长分析：按产品、技术、应用、最终用户 - 行业预测 (2023-2030)Global Digital PCR and Real-time PCR Market Size, Share, Growth Analysis, By Product, By Technology(Digital PCR, and quantitative PCR ), By Application, By End-user - Industry Forecast 2023-2030 |
||||||
全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场规模将从 2022 年的 58,064.8 亿美元增至 2030 年的 121,888.8 亿美元，并且在预测期内（2023 年）将持续增长。预计2019年至2030年復合年增长率为8.8%。
遗传性疾病和传染病的流行、PCR、法医学和其他实验室的技术进步正在推动市场增长。 然而，与 PCR 相关的技术限制和使用替代检测方法进行疾病检测可能会阻碍市场增长。
促进因素
在各种传染病的流行、遗传疾病数量的增加以及人类基因组计划的成功的推动下，预计该市场将在预测期内显着增长。 数字 PCR 和实时 PCR 是强大的分子生物学技术，可用于检测和定量核酸（细胞的遗传物质）。 这些技术具有广泛的应用，包括临床诊断、研究和法医学。 传染病爆发是市场的主要驱动因素。 这些疾病包括艾滋病毒/艾滋病、疟疾、肺结核和流感。 数字PCR和实时PCR可以快速准确地检测这些疾病，这对于早期诊断和治疗至关重要。 遗传疾病的增加是市场的另一个主要驱动力。 这些疾病包括囊性纤维化、镰状细胞病和泰萨克斯病。 数字PCR和实时PCR可用于诊断这些疾病并跟踪治疗效果。 人类基因组计划的成功也导致了对数字PCR和实时PCR的需求增加。 人类基因组计划提供了大量有关人类遗传学的信息，可用于开发数字 PCR 和实时 PCR 的新诊断和治疗应用。
抑制因素
dPCR/qPCR 的技术限制，例如需要在 PCR 反应的指数阶段进行信号测量以及需要优化和验证检测程序，可能会阻碍市场增长。 这些限制可能会由于反应抑製或无法测试目标分子而导致目标检测失败。
主要市场趋势
随着病毒感染患者数量的增加，用于发现这些疾病的治疗药物和生物标誌物的数字 PCR 技术的发展正在取得进展。 数字 PCR 技术也得到了改进，可以检测罕见的癌症生物标誌物。 研究人员可以将数字液滴 PCR (ddPCR) 与分子生物学技术结合使用来识别新的癌症生物标誌物。
本报告研究和分析了全球数字PCR（dPCR）和实时PCR（qPCR）市场，提供市场动态和前景、细分分析、公司简介等。
目录
执行摘要
调查方法
母公司市场分析
- 市场概览
- 市场规模
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 作业
主要市场考虑因素
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 知识产权分析
- 贸易分析
- 启动分析
- 原材料分析
- 创新矩阵
- 管道产品分析
- 宏观经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
市场动态与展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 作业
- 监管情况
- 波特的分析
- 对未来中断的特殊考虑
全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场：按产品划分
- 市场概览
- 试剂/消耗品
- 设备
- 软件
全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场：按技术划分
- 市场概览
- 数字 PCR (dPCR)
- 定量 PCR (qPCR)
全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场：按应用划分
- 市场概览
- 研究用途
- 临床应用
- 取证应用
全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场：按最终用户划分
- 市场概览
- 医院/诊断中心
- 研究机构/学术机构
- 临床研究所
- 其他
按地区划分的全球数字 PCR (dPCR)/实时 PCR (qPCR) 市场规模
- 市场概览
- 北美
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲
竞争格局
- 排名前 5 名的公司比较
- 主要公司的市场定位（2021 年）
- 主要市场参与者采取的策略
- 关键成功策略
- 近期市场活动
- 主要公司的市场份额（2021 年）
主要公司简介
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN NV
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Fluidigm Corporation
- Merck KGaA
- Takara Bio Inc.
- Illumina, Inc.
- Promega Corporation
- Abbott Laboratories
- Danaher Corporation
- Becton, Dickinson and Company
- GE Healthcare Life Sciences
- Eppendorf AG
- Analytik Jena AG
- Enzo Biochem, Inc.
- Luminex Corporation
- BioFire Diagnostics, Inc.
- Oxford Nanopore Technologies Ltd.
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2021 and is poised to grow from USD 5806.48 billion in 2022 to USD 12018.88 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030)
Real-time PCR and digital PCR are two widely used techniques for detecting and quantifying nucleic acids. Real-time PCR is a well-established technology that is known for its rapid and sensitive detection of nucleic acids in biological samples. Digital PCR, on the other hand, provides an absolute measure of target nucleic acid molecules by partitioning each sample into thousands of individual reactions.
The increasing prevalence of genetic and infectious diseases, as well as technological advancements in PCR, forensic, and other research laboratories, are driving the growth of the dPCR and qPCR market. However, technical limitations associated with PCR and the use of alternative assays to detect diseases may hinder market growth..
Segments covered in this report:
The Global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented based on the product, technology, application, end-user, and region. Based on product, global digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into reagents and consumables, instruments, and software. Based on technology, the digital PCR (dPCR) and real-time PCR (qPCR) market is segmented into digital PCR (dPCR), and quantitative PCR (qPCR). Based on application, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated into research applications, clinical applications, and forensic applications. Based on end-user, the digital PCR (dPCR) and real-time PCR (qPCR) market is bifurcated as hospitals & diagnostic centers, research laboratories & academic institutes, clinical research organizations, and others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
The global digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow significantly during the forecast period, driven by the widespread prevalence of various infections, increasing genetic disorders, and the successful completion of the Human Genome Project. Digital PCR and real-time PCR are powerful molecular biology techniques that can be used to detect and quantify nucleic acids, the genetic material of cells. These techniques are used in a wide range of applications, including clinical diagnostics, research, and forensics. The increasing prevalence of infectious diseases is a major driver of the dPCR and qPCR market. These diseases include HIV/AIDS, malaria, tuberculosis, and influenza. Digital PCR and real-time PCR can be used to rapidly and accurately detect these diseases, which is essential for early diagnosis and treatment. Increasing genetic disorders is another major driver of the dPCR and qPCR market. These disorders include cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Digital PCR and real-time PCR can be used to diagnose these disorders, as well as to track the effectiveness of treatments. The successful completion of the Human Genome Project has also led to increased demand for digital PCR and real-time PCR. The Human Genome Project has provided a wealth of information about human genetics, which can be used to develop new diagnostic and therapeutic applications for digital PCR and real-time PCR.
Restraint
The technical limitations of dPCR and qPCR techniques, such as the need for signal measurement during the exponential phase of the PCR reaction and the optimization and validation of assay procedures, may hinder market growth. These limitations could lead to target detection failures due to reaction constraints or the inability to examine target molecules.
Key Market Trend
The increasing number of patients with viral infections has led to the development of digital PCR techniques to discover drugs or biomarkers for these diseases. Digital PCR techniques have also been improved to detect rare cancer biomarkers. Researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to identify new cancer biomarkers.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product
- Market Overview
- Reagents and consumables
- instruments
- and software
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Technology
- Market Overview
- Digital PCR (dPCR)
- and quantitative PCR (qPCR)
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application
- Market Overview
- Research applications
- clinical applications
- and forensic applications
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by End-user
- Market Overview
- Hospitals & diagnostic centers
- research laboratories & academic institutes
- clinical research organizations
- and others
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Analytik Jena AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioFire Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
数位 PCR 和即时PCR市场：按类型、产品类型、应用和最终用户 - 2024-2030 年全球预测
数位 PCR 市场：按产品类型、技术、应用和最终用户划分 - 2024-2030 年全球预测
2024-2032 年按产品类型、技术、应用和地区分類的数位 PCR 市场报告
全球数位 PCR 市场规模、份额、成长分析，按技术（液滴数位 PCR 和基于晶片的数位 PCR）、产品类型、应用 - 产业预测 2024-2031
即时PCR、数位 PCR、端点 PCR 2024 年全球市场报告
全球即时 PCR、数位 PCR 和终点 PCR 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
即时 PCR (qPCR)、终点 PCR 和 dPCR 市场规模、份额和趋势分析报告：按技术、按产品、按应用、按地区和细分趋势：2024-2030 年
数位 PCR 和定量 PCR 市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测
即时 PCR 和数数位PCR 的全球市场：趋势、预测和竞争分析（截至 2030 年）
即时 PCR、数位 PCR 和终点 PCR 市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按技术、产品、按应用、地区、竞争预测和机会细分，2018 年-2028F